Amber Cornelius - Concepedia

Concepedia

Author

Amber Cornelius

New York University

Also Known As

Amber Cornelius, Amber R Cornelius, Amber R. Cornelius

34

Publications

1.4K

Citations

19

H-Index

40

Concepts

All Affiliations

New York University NYU Langone Health University of Copenhagen New York Genome Center LEO Foundation

AC

About

Amber Cornelius is an author at New York University specializing in medicine, immunology, and vaccine development.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	7	7	292
2	Immunology	7	7	292
3	Public Health	1	1	162
4	Epidemiology	1	1	26
5	Microbiology	1	1	18

Amber Cornelius

×

23

Publications

1.4K

Citations

19

H-Index

	Year	Citations
Methotrexate hampers immunogenicity to BNT162b2 mRNA COVID-19 vaccine in immune-mediated inflammatory disease Rebecca H. Haberman, Ramin S. Herati, David Simón, Annals of the Rheumatic Diseases	2021	264
Systems Analysis of the Human Pulmonary Arterial Hypertension Lung Transcriptome Robert S. Stearman, Quan M. Bui, Gil Speyer, American Journal of Respiratory Cell and Molecular Biology GeneticsImmunologyPathologyPulmonary HypertensionGene Expression Profiling	2018	162
Evaluation of Immune Response and Disease Status in Systemic Lupus Erythematosus Patients Following <scp>SARS</scp>–<scp>CoV</scp>‐2 Vaccination Peter Izmirly, Mimi Kim, Marie I. Samanovic, Arthritis & Rheumatology	2021	149
Neutralization of viruses with European, South African, and United States SARS-CoV-2 variant spike proteins by convalescent sera and BNT162b2 mRNA vaccine-elicited antibodies Takuya Tada, Belinda M. Dcosta, Marie Samanovic-Golden,	2021	114
Comparison of Neutralizing Antibody Titers Elicited by mRNA and Adenoviral Vector Vaccine against SARS-CoV-2 Variants Takuya Tada, Hao Zhou, Marie I. Samanovic,	2021	108
Robust immune responses are observed after one dose of BNT162b2 mRNA vaccine dose in SARS-CoV-2–experienced individuals Marie I. Samanovic, Amber Cornelius, Sophie L. Gray-Gaillard, Science Translational Medicine	2022	97
Robust immune responses after one dose of BNT162b2 mRNA vaccine dose in SARS-CoV-2 experienced individuals Marie I. Samanovic, Amber Cornelius, Sophie L. Gray-Gaillard,	2021	72
Convalescent-Phase Sera and Vaccine-Elicited Antibodies Largely Maintain Neutralizing Titer against Global SARS-CoV-2 Variant Spikes Takuya Tada, Belinda M. Dcosta, Marie I. Samanovic, mBio	2021	70
Neutralization of SARS-CoV-2 Variants by mRNA and Adenoviral Vector Vaccine-Elicited Antibodies Takuya Tada, Hao Zhou, Marie I. Samanovic, Frontiers in Immunology	2022	50
Methotrexate Hampers Immunogenicity to BNT162b2 mRNA COVID-19 Vaccine in Immune-Mediated Inflammatory Disease Rebecca H. Haberman, Ramin S. Herati, David Simón,	2021	42

Page 1